LongRPRXJul 2026
Royalty Pharma
Pelican Bay's Royalty Pharma position has appreciated as investors gained confidence in management's ability to acquire new pharmaceutical royalties on attractive terms. The fund…
RPRX
Which hedge funds are long RPRX?
1 published idea on Royalty Pharma across 1 fund — 1 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Royalty Pharma: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.